A digital obesity clinic, Embla, is associated with 16.7% weight loss over 64 weeks, matching previous semaglutide trial ...

By Tarun Sai Lomte While GLP-1 receptor agonists like semaglutide help with weight loss, new research shows users often fall ...

New research published in the American Journal of Health-System Pharmacy suggests a possible link between the GLP-1 drug ...

The analysis of 11 weight-loss drug studies by the University of Oxford found that patients typically lost 8kg (18lb) after ...

New animal research being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May), reveals ...

When weight loss is equal, though, the GLP-1s seem to provide larger benefits. Researchers say prospective studies are needed ...

Limited effectiveness, weight regain, and high prevalence of adverse events are the three key limitations of ...

Taking semaglutide and liraglutide — a lesser-known active ingredient — medications for weight loss cut their consumption by nearly two-thirds in just four months. At such a critical moment in US ...

New animal research being presented at the European Congress on Obesity (ECO25) in Malaga, Spain (11–14 May), reveals ...

In SELECT, semaglutide was associated with a 41% reduction in major CV events within 6 months — ie, before weight loss or ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Q1 2025 Earnings Call Transcript May 13, 2025Fractyl Health, Inc. Common Stock reports earnings inline with expectations.